Sabapathy S, Neslusan C, Yoong K, Teschemaker A, Johansen P, Willis M. COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA. J Popl Ther Clin Pharmacol [Internet]. 2018 Nov. 3 [cited 2024 Nov. 19];23(2). Available from: https://mail.jptcp.com/index.php/jptcp/article/view/206